Epclusa (sofosbuvir/velpatasvir)

pCPA File Number: 20912

Negotiation Status:

Concluded with an LOI

Indication(s):

Chronic Hepatitis C

Sponsor/Manufacturer:

Gilead Sciences Canada Inc.

CADTH Project Number:

SR0486-000

pCPA Engagement Letter Issued:

2016-10-26

Negotiation Process Concluded:

2017-02-17